对高血压的单药组合疗法:新的证据和新的挑战:对高血压的组合疗法
Martin Rosas-Peralta1, Giuseppe Mancia2, Miguel Camafort3
1GREHTA (Group of Experts in Hypertension). México.
Trends in cardiovascular medicine
|July 3, 2025
概括
高血压 (HTN) 管理需要谨慎地分层心血管风险. 这项研究提出了一种实用的临床方法来指导药理疗法,强调个性化的治疗策略,以获得更好的患者结果.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 公共卫生 公共卫生
背景情况:
- 高血压 (HTN) 是心血管事件和死亡的主要全球风险因素,影响全球大约30%的成年人.
- 目前的心血管风险分层表具有局限性,需要实用的临床方法来有效管理.
研究的目的:
- 讨论高血压患者心血管风险分层的挑战.
- 提出一种实用的临床方法来确定心血管风险和指导药物治疗.
- 为初级保健医生提供关于管理高血压的建议.
主要方法:
- 该研究审查了现有的风险分层方法及其局限性.
- 它概述了一种基于风险因素,血压升高,目标器官损伤和心血管事件史的临床方法.
- 它讨论了当前的双重和潜在的三重治疗建议.
主要成果:
- 综合多种因素的实用临床方法被提出为复杂风险尺度的可行替代方案.
- 强调了双重治疗的必要性,并建议在严重高血压的高风险患者中启动三重治疗.
- 这篇文章旨在为初级保健医生提供有效高血压管理的工具.
结论:
- 有效的心血管风险分层对于优化高血压治疗至关重要.
- 简化临床方法可以帮助初级保健医生及时做出治疗决策.
- 个性化治疗策略,包括潜在的三重疗法,对于管理高风险高血压患者至关重要.
相关概念视频
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
48
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
48
01:27Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
01:28Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
54
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
54
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
893
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
893
01:26Atherosclerosis III: Management
41
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41